Changes to OTC derivatives margining and what it means for the buy-side

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Changes to OTC derivatives margining and what it means for the buy-side

euroclear logo

As buyside firms look at their options for sourcing, mobilising and protecting collateral assets to be used as margin, whether for cleared or non-cleared OTC derivatives instruments, they very soon come up against problems of fragmentation.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article